ANTIBODY MEDIATED REJECTION :
Antibody mediated rejection after lung transplantation
... Abstract: Antibody-mediated rejection (AMR) has been identified as a significant form of acute allograft dysfunction in lung transplantation. The development of consensus diagnostic criteria has ...
11
Antibody-mediated rejection after kidney transplantation
... of antibody activity; and 3) serological evidence of circulating DSA or antibodies against other donor endothelial ...negative antibody mediated rejection has been recently reported, but still ...
5
Treatment of acute antibody-mediated rejection using Rituximab
... Acute Antibody Mediated Rejection is one type of acute rejection in which antibodies are directed against donor specific human leukocyte antigen ...
7
The Effect of Bortezomib on Antibody Mediated Rejection after Kidney Transplantation
... 1 The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul; Departments of 2 Surgery, 3 Internal Medicine (Nephrology), 4 Laboratory Medicine, and 5 Pathology, Yonsei University College of ...
5
Current perspectives on antibody-mediated rejection after lung transplantation
... of antibody-mediated rejection (AMR) in lung transplantation remain ...cellular rejection and ...of rejection and conduct clinical trials to identify optimal treatment ...
7
Antibody mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies
... is antibody-mediated rejection (AMR) caused by anti-donor HLA ...to antibody-mediated allograft injury as well as current and emerging ...
14
Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection
... 21. Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, et al. Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant. 2012; 12(3):563–70. Epub 2012/02/04. ...
13
Banff lesions and renal allograft survival in chronic-active antibody mediated rejection
... Aims: Chronic-active antibody mediated rejection (c-aABMR) is a major cause of kidney graft loss. Currently, little is known about the relation between histopathologic parameters and renal allograft ...
5
Clazakizumab in late antibody mediated rejection: study protocol of a randomized controlled pilot trial
... 29. Streitz M, Miloud T, Kapinsky M, Reed MR, Magari R, Geissler EK, et al. Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study. Transplant Res. ...
13
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
... Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled ...chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A ...
16
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
... T-cell–mediated rejection and acute kidney in- jury and common after antibody-mediated rejection or ...HLA antibody and clinical data to explain each ...causes: rejection ...
12
Eculizumab to Treat Antibody-Mediated Rejection in a 7-Year-Old Kidney Transplant Recipient
... abstract We report on successful early eculizumab administration to treat acute antibody-mediated rejection (ABMR) in a highly sensitized kidney transplant recipient. The recipient is a 7-year-old ...
7
Eculizumab to Treat Antibody-Mediated Rejection in a 7-Year-Old Kidney Transplant Recipient
... We report on successful early eculizumab administration to treat acute antibody-mediated rejection (ABMR) in a highly sensitized kidney transplant recipient. The recipient is a 7-year-old boy who ...
7
Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
... active antibody-mediated rejection; CCI: Charlson comorbidity index; DSA: Donor specific antibodies; eGFR: Estimated glomerular filtrated rate; IFTA: Interstitial fibrosis and tubular atrophy; IVIG: ...
9
Original Article Acute cellular rejection and antibody-mediated rejection in endomyocardial biopsy after heart transplantation: a retrospective study from a single medical center
... cellular rejection and antibody-mediated rejection after heart transplantation, as detected by ...cellular rejection (ACR) and antibody-mediated rejection (AMR) by ...
8
Research Article Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection
... by antibody- mediated processes [2, ...acute rejection decreased by 12.2% [4], chronic antibody-mediated rejection (cAMR) is considered as the main cause for late allograft ...
15
Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection
... Chronic-active Antibody Mediated Rejection (c-aABMR) is an important cause of renal allograft dysfunction over time, often presenting as a continuous decline in allograft function, either with or ...
9
Treatment of antibody-mediated rejection with eculizumab
... Regiones 2 y 3 de la Fracción constante de la cadena Pesada IgG4 humana Región constante 1 y bisagra de la cadena pesadaIgG2 humana Cadena ligera variable Cadena pesad[r] ...
31
CD25 CD20 CD20 ABO CD25 CD20. T T cell mediated rejection. antibody mediated rejection
... Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.[r] ...
5
Diagnosis and Management of Antibody‐Mediated Rejection: Current Status and Novel Approaches
... C4d is a split product of C4 activation and has no known biological action. It may be activated by the classical and lectin complement pathways and serves as a footprint of antibody–antigen interactions on the ...
17